3,210
Views
36
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

150th Anniversary Series: Desmosomes and the Hallmarks of Cancer

&
Pages 15-28 | Received 04 Aug 2014, Accepted 07 Apr 2015, Published online: 02 Jul 2015

REFERENCES

  • Aberle H, Bierkamp C, Torchard D, Serova O, Wagner T, Natt E, Wirsching J, Heidkämper C, Montagna M, Lynch HT, Lenoir GM, Scherer G, Feunteun J, Kemler R (1995). The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. Proc Natl Acad Sci USA. 92: 6384–6388.
  • Adams MJ, Reichel MB, King IA, Marsden MD, Greenwood MD, Thirlwell H, Arnemann J, Buxton RS, Ali RR (1998). Characterization of the regulatory regions in the human desmoglein genes encoding the pemphigus foliaceus and pemphigus vulgaris antigens. Biochem J. 329: 165–174.
  • Aho S (2004). Plakin proteins are coordinately cleaved during apoptosis but preferentially through the action of different caspases. Exp Dermatol. 13: 700–707.
  • Aktary Z, Kulak S, Mackey J, Jahroudi N, Pasdar M (2013). Plakoglobin interacts with the transcription factor p53 and regulates the expression of 14–3-3sigma. J Cell Sci. 126: 3031–3042.
  • Aktary Z, Pasdar M (2012). Plakoglobin: role in tumorigenesis and metastasis. Int J Cell Biol. 2012: 189521.
  • Aktary Z, Pasdar M (2013). Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion. PLoS One. 8: e78388.
  • Al-Amoudi A, Diez DC, Betts MJ, Frangakis AS (2007). The molecular architecture of cadherins in native epidermal desmosomes. Nature. 450: 832–839.
  • Al-Jassar C, Bikker H, Overduin M, Chigey M (2013). Mechanistic basis of desmosome-targeted disease. J Mol Biol. 425: 4006–4022.
  • Alazawi WO, Morris LS, Stanley MA, Garrod DR, Coleman N (2003). Altered expression of desmosomal components in high-grade squamous intraepithelial lesions of the cervix. Virchows Arch. 443: 51–56.
  • Allen E, Yu Q-C, Fuchs E (1996). Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation and epidermal differentiation. J Cell Biol. 135: 215–225.
  • Amagai M, Stanley JR (2012). Desmoglein as a target in skin disease and beyond. J Invest Dermatol. 132: 776–784.
  • Aoyama Y, Nagai M, Kitajima Y (2010). Binding of pemphigus vulgaris IgG to antigens in desmosome core domains excludes immune complexes rather than directly splitting desmosomes. Br J Dermatol. 162: 1049–1055.
  • Arnoux V, Nassour M, L’Helgoualc'h A, Hipskind RA, Savagner P (2008). Erk5 controls Slug expression and keratinocyte activation during wound healing. Mol Biol Cell. 19: 4738–4749.
  • Asimaki A, Tandri H, Duffy ER, Winterfield JR, Mackey-Bojack S, Picken MM, Cooper LT, Wilber DJ, Marcus FI, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, Stevenson WG, McKenna WJ, Gautam S, Remick DG, Calkins H, Saffitz JE (2011). Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 4: 743–752.
  • Bailey CK, Mittal MK, Misra S, Chaudhuri G (2012). High motility of triple-negative breast cancer cells is due to repression of plakoglobin gene by metastasis modulator protein SLUG. J Biol Chem. 287: 19472–19486.
  • Balda MS, Matter K (2003). Epithelial cell adhesion and the regulation of gene expression. Trends Cell Biol. 13: 310–318.
  • Barber AG, Castillo-Martin M, Bonal DM, Rybicki BA, Christiano AM, Cordon-Cardo C (2014). Characterization of desmoglein expression in the normal prostatic gland. Desmoglein 2 is an independent prognostic factor for aggressive prostate cancer. PLoS One. 9: e98786.
  • Baron S, Hoang A, Vogel H, Attardi LD (2012). Unimpaired skin carcinogenesis in Desmoglein 3 knockout mice. PLoS One. 7: e50024.
  • Bass-Zubek AE, Hobbs RP, Amargo EV, Garcia NJ, Hsieh SN, Chen X, Wahl JK III, Denning MF, Green KJ (2008). Plakophilin 2: a critical scaffold for PKC alpha that regulates intercellular junction assembly. J Cell Biol. 181: 605–613.
  • Beaudry VG, Ihrie RA, Jacobs SB, Nguyen B, Pathak N, Park E, Attardi LD (2010a). Loss of the desmosomal component Perp impairs wound healing in vivo. Dermatol Res Pract. 2010: 759731.
  • Beaudry VG, Jiang D, Dusek RL, Park EJ, Knezevich S, Ridd K, Vogel H, Bastian BC, Attardi LD (2010b). Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis. PLoS Genet. 6: e1001168.
  • Bech-Serra JJ, Santiago-Josefat B, Esselens C, Saftig P, Baselga J, Arribas J, Canals F (2006). Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis. Mol Cell Biol. 26: 5086–5095.
  • Bektas M, Jolly PS, Berkowitz P, Amagai M, Rubenstein DS (2013). A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis. J Biol Chem. 288: 9447–9456.
  • Berika M, Garrod D (2014). Desmosomal adhesion in vivo. Cell Commun Adhes. 21: 65–75.
  • Berkowitz P, Hu P, Liu Z, Diaz LA, Enghild JJ, Chua MP, Rubenstein DS (2005). Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J Biol Chem . 280: 23778–23784.
  • Berkowitz P, Hu P, Warren S, Liu Z, Diaz LA, Rubenstein DS (2006). p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc Natl Acad Sci U S A. 103: 12855–12860.
  • Biedermann K, Vogelsang H, Becker I, Plaschke S, Siewert JR, Hofler H, Keller G (2005). Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer. J Pathol. 207: 199–206.
  • Borgono CA, Michael IP, Komatsu N, Jayakumar A, Kapadia R, Clayman GL, Sotiropoulou G, Diamandis EP (2007). A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem. 282: 3640–3652.
  • Bouameur JE, Favre B, Borradori L (2014). Plakins, a versatile family of cytolinkers: roles in skin integrity and in human disease. J Invest Dermatol. 134: 885–894.
  • Boyer B, Tucker GC, Valles AM, Gavrilovic J, Thiery JP (1989). Reversible transition towards a fibroblastic phenotype in a rat carcinoma cell line. Int J Cancer Suppl. 4: 69–75.
  • Breault JE, Shiina H, Igawa M, Ribeiro-Filho LA, Deguchi M, Enokida H, Urakami S, Terashima M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R (2005). Methylation of the γ-catenin gene is associated with poor prognosis of renal cell carcinoma. Clin Cancer Res. 11: 557–564.
  • Brennan D, Hu Y, Choi YW, Whitaker-Menezes D, O’Brian T, Uitto J, Rodeck U, Mahoney MG (2007). Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes. J Cell Sci. 120: 758–771.
  • Brennan D, Mahoney MG (2009). Increased expression of Dsg2 in malignant skin carcinomas: A tissue-microarray based study. Cell Adh Migr. 3: 148–154.
  • Brennan D, Peltonen S, Dowling A, Medhat W, Green KJ, Wahl JK III, Del Galdo F, Mahoney MG (2012). A role for caveolin-1 in desmoglein binding and desmosome dynamics. Oncogene. 31: 1636–1648.
  • Brooke MA, Etheridge SL, Kaplan N, Simpson C, O’Toole EA, Ishida-Yamamoto A, Marches O, Getsios S, Kelsell DP (2014). iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function. Hum Mol Genet. 23: 4064–4076.
  • Brooke MA, Nitoiu D, Kelsell DP (2012). Cell-cell connectivity: desmosomes and disease. J Pathol. 226: 158–171.
  • Brown L, Waseem A, Cruz IN, Szary J, Gunic E, Mannan T, Unadkat M, Yang M, Valderrama F, O’Toole EA, Wan H (2014). Desmoglein 3 promotes cancer cell migration and invasion by regulating activator protein 1 and protein kinase C-dependent-Ezrin activation. Oncogene. 33: 2363–2374.
  • Burdett ID, Sullivan KH (2002). Desmosome assembly in MDCK cells: transport of precursors to the cell surface occurs by two phases of vesicular traffic and involves major changes in centrosome and Golgi location during a Ca2+ shift. Exp Cell Res. 276: 296–309.
  • Calkins CC, Setzer SV, Jennings JM, Summers S, Tsunoda K, Amagai M, Kowalczyk AP (2006). Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem. 281: 7623–7634.
  • Chen J, Nekrasova OE, Patel DM, Klessner JL, Godsel LM, Koetsier JL, Amargo EV, Desai BV, Green KJ (2012a). The C-terminal unique region of desmoglein 2 inhibits its internalization via tail-tail interactions. J Cell Biol. 199: 699–711.
  • Chen J, O’Shea C, Fitzpatrick JE, Koster MI, Koch PJ (2012b). Loss of Desmocollin 3 in skin tumor development and progression. Mol Carcinog. 51: 535–545.
  • Chen YJ, Chang JT, Lee L, Wang HM, Liao CT, Chiu CC, Chen PJ, Cheng AJ (2007). DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Oncogene. 26: 467–476.
  • Chen YJ, Lee LY, Chao YK, Chang JT, Lu YC, Li HF, Chiu CC, Li YC, Li YL, Chiou JF, Cheng AJ (2013). DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway. PLoS One. 8: e64088.
  • Chidgey M, Brakebusch C, Gustafsson E, Cruchley A, Hail C, Kirk S, Merritt A, North A, Tselepis C, Hewitt J, Byrne C, Fässler R, Garrod D (2001). Mice lacking desmocollin 1 show epidermal fragility accompanied by barrier defects and abnormal differentiation. J Cell Biol. 155: 821–832.
  • Chidgey M, Dawson C (2007). Desmosomes: a role in cancer? Brit J Cancer. 96: 1783–1787.
  • Chitaev NA, Troyanovsky SM (1997). Direct Ca2+-dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion. J Cell Biol. 138: 193–201.
  • Chun MG, Hanahan D (2010). Genetic deletion of the desmosomal component desmoplakin promotes tumor microinvasion in a mouse model of pancreatic neuroendocrine carcinogenesis. PLoS Genet. 6: e1001120.
  • Cirillo N (2014). 150th anniversary series: desmosomes in physiology and disease. Cell Commun Adhes. 21: 85–88.
  • Cirillo N, Al-Jandan BA (2013). Desmosomal adhesion and pemphigus vulgaris: the first half of the story. Cell Commun Adhes. 20: 1–10.
  • Cirillo N, Femiano F, Gombos F, Lanza A (2007). Metalloproteinase 9 is the outer executioner of desmoglein 3 in apoptotic keratinocytes. Oral Dis. 13: 341–345.
  • Cirillo N, Lanza M, De Rosa A, Cammarota M, La Gatta A, Gombos F, Lanza A (2008). The most widespread desmosomal cadherin, desmoglein 2, is a novel target of caspase 3-mediated apoptotic machinery. J Cell Biochem. 103: 598–606.
  • Cui T, Chen Y, Yang L, Knösel T, Huber O, Pacyna-Gengelbach M, Petersen I (2012a). The p53 target gene desmocollin 3 acts as a novel tumor suppressor through inhibiting EGFR/ERK pathway in human lung cancer. Carcinogenesis. 33: 2326–2333.
  • Cui T, Chen Y, Yang L, Knosel T, Zoller K, Huber O, Petersen I (2011). DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer. Br J Cancer. 104: 1013–1019.
  • Cui T, Chen Y, Yang L, Mireskandari M, Knosel T, Zhang Q, Kohler LH, Kunze A, Presselt N, Petersen I (2012b). Diagnostic and prognostic impact of desmocollins in human lung cancer. J Clin Pathol. 65: 1100–1106.
  • De Bruin A, Muller E, Wurm S, Caldelari R, Wyder M, Wheelock MJ, Suter MM (1999). Loss of invasiveness in squamous cell carcinoma cells overexpressing desmosomal cadherins. Cell Adhes Commun. 7: 13–28.
  • DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008). The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7: 11–20.
  • Delva E, Jennings JM, Calkins CC, Kottke MD, Faundez V, Kowalczyk AP (2008). Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. J Biol Chem. 283: 18303–18313.
  • Delva E, Kowalczyk AP (2009). Regulation of cadherin trafficking. Traffic. 10: 259–267.
  • Demlehner MP, Schäfer S, Grund C, Franke WW (1995). Continual assembly of half-desmosomal structures in the absence of cell contacts and their frustrated endocytosis: a coordinated Sisyphus cycle. J Cell Biol. 131: 745–760.
  • Dusek RL, Attardi LD (2011). Desmosomes: new perpetuators in tumor suppression. Nat Rev Cancer. 11: 317–323.
  • Dusek RL, Bascom JL, Vogel H, Baron S, Borowsky AD, Bissell MJ, Attardi LD (2012). Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer. Breast Cancer Res. 14: R65.
  • Dusek RL, Getsios S, Chen F, Park JK, Amargo EV, Cryns VL, Green KJ (2006). The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes. J Biol Chem. 281: 3614–3624.
  • Dusek RL, Godsel LM, Chen F, Strohecker AM, Getsios S, Harmon R, Müller EJ, Caldelari R, Cryns VL, Green KJ (2007). Plakoglobin deficiency protects keratinocytes from apoptosis. J Invest Dermatol. 127: 792–801.
  • Edme N, Downward J, Thiery JP, Boyer B (2002). Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways. J Cell Sci. 115: 2591–2601.
  • Ellerbroek SM, Halbleib JM, Benavidez M, Warmka JK, Wattenberg EV, Stack MS, Hudson LG (2001). Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. Cancer Res. 61: 1855–1861.
  • Ferone G, Mollo MR, Thomason HA, Antonini D, Zhou H, Ambrosio R, De Rosa L, Salvatore D, Getsios S, van Bokhoven H, Dixon J, Missero C (2013). p63 control of desmosome gene expression and adhesion is compromised in AEC syndrome. Hum Mol Genet. 22: 531–543.
  • Franzen CA, Todorovic V, Desai BV, Mirzoeva S, Yang XJ, Green KJ, Pelling JC (2012). The desmosomal armadillo protein plakoglobin regulates prostate cancer cell adhesion and motility through vitronectin-dependent Src signaling. PLoS One. 7: e42132.
  • Funakoshi S, Ezaki T, Kong J, Guo RJ, Lynch JP (2008). Repression of the desmocollin 2 gene expression in human colon cancer cells is relieved by the homeodomain transcription factors Cdx1 and Cdx2. Mol Cancer Res. 6: 1478–1490.
  • Garrod D, Tabernero L (2014). Hyper-adhesion: a unique property of desmosomes. Cell Commun Adhes. 30: 1–8.
  • Garrod DR (2013). The assay that defines desmosome hyperadhesion. J Invest Dermatol. 133: 576–577.
  • Garrod DR, Berika MY, Bardsley WF, Holmes D, Tabernero L (2005). Hyperadhesion in desmosomes: its regulation in wound healing and possible relationship to cadherin crystal structure. J Cell Sci. 118: 5743–5754.
  • Gaudry CA, Palka HL, Dusek RL, Huen AC, Khandekar MJ, Hudson LG, Green KJ (2001). Tyrosine-phosphorylated plakoglobin is associated with desmogleins but not desmoplakin after epidermal growth factor receptor activation. J Biol Chem. 276: 24871–24880.
  • Getsios S, Amargo EV, Dusek RL, Ishii K, Sheu L, Godsel LM, Green KJ (2004). Coordinated expression of desmoglein 1 and desmocollin 1 regulates intercellular adhesion. Differentiation. 72: 419–433.
  • Getsios S, Simpson CL, Kojima S, Harmon R, Sheu LJ, Dusek RL, Cornwell M, Green KJ (2009). Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol. 185: 1243–1258.
  • Gilmore AP (2005). Anoikis. Cell Death Diff. 12: 1473–1477.
  • Godsel LM, Hsieh SN, Amargo EV, Bass AE, Pascoe-McGillicuddy LT, Huen AC, Thorne ME, Gaudry CA, Park JK, Myung K, Goldman RD, Chew TL, Green KJ (2005). Desmoplakin assembly dynamics in four dimensions: multiple phases differentially regulated by intermediate filaments and actin. J Cell Biol. 171: 1045–1059.
  • Gould JJ, Kenney PA, Rieger-Christ KM, Silva Neto B, Wszolek MF, LaVoie A, Holway AH, Spurrier B, Austin J, Cammarata BK, Canes D, Libertino JA, Summerhayes IC (2010). Identification of tumor and invasion suppressor gene modulators in bladder cancer by different classes of histone deacetylase inhibitors using reverse phase protein arrays. J Urol. 183: 2395–2402.
  • Greening DW, Kapp EA, Ji H, Speed TP, Simpson RJ (2013). Colon tumour secretopeptidome: insights into endogenous proteolytic cleavage events in the colon tumour microenvironment. Biochim Biophys Acta. 1834: 2396–2407.
  • Grivennikov SI, Greten FR, Karin M (2010). Immunity, inflammation, and cancer. Cell. 140: 883–899.
  • Hakimelahi S, Parker HR, Gilchrist AJ, Barry M, Li Z, Bleackley RC, Pasdar M (2000). Plakoglobin regulates the expression of the anti-apoptotic protein Bcl-2. J Biol Chem. 275: 10905–10911.
  • Hamidov Z, Altendorf-Hofmann A, Chen Y, Settmacher U, Petersen I, Knosel T (2011). Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma. J Clin Pathol. 64: 990–994.
  • Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell. 100: 57–70.
  • Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell. 144: 646–674.
  • Hanakawa Y, Matsuyoshi N, Stanley JR (2002). Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion. J Invest Dermatol. 119: 27–31.
  • Harada H, Iwatsuki K, Ohtsuka M, Han GW, Kaneko F (1996). Abnormal desmoglein expression by squamous cell carcinoma cells. Acta Derm Venereol. 76: 417–420.
  • Hardman MJ, Liu K, Avilion AA, Merritt A, Brennan K, Garrod DR, Byrne C (2005). Desmosomal cadherin misexpression alters β-catenin stability and epidermal differentiation. Mol Cell Biol. 25: 969–978.
  • Harmon RM, Green KJ (2013). Structural and functional diversity of desmosomes. Cell Commun Adhes. 20: 171–187.
  • Harmon RM, Simpson CL, Johnson JL, Koetsier JL, Dubash AD, Najor NA, Sarig O, Sprecher E, Green KJ (2013). Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation. J Clin Invest. 123: 1556–1570.
  • Hartlieb E, Kempf B, Partilla M, Vigh B, Spindler V, Waschke J (2013). Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion. PLoS One. 8: e53739.
  • Hatzfeld M (2007). Plakophilins: Multifunctional proteins or just regulators of desmosomes. Biochim Biophys Acta. 1773: 69–77.
  • Hatzfeld M, Wolf A, Keil R (2014). Plakophilins in desmosomal adhesion and signaling. Cell Commun Adhes. 21: 25–42.
  • He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998). Identification of c-myc as a target of the APC pathway. Science. 281: 1509–1512.
  • He W, Cowin P, Stokes DL (2003). Untangling desmosomal knots with electron tomography. Science. 302: 109–113.
  • Hoffmeyer K, Raggioli A, Rudloff S, Anton R, Hierholzer A, Del Valle I, Hein K, Vogt R, Kemler R (2012). Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells. Science. 336: 1549–1554.
  • Hoschuetzky H, Aberle H, Kemler R (1994). β-Catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol. 127: 1375–1380.
  • Huang CC, Lee TJ, Chang PH, Lee YS, Chuang CC, Jhang YJ, Chen YW, Chen CW, Tsai CN (2010). Desmoglein 3 is overexpressed in inverted papilloma and squamous cell carcinoma of sinonasal cavity. Laryngoscope. 120: 26–29.
  • Huber O, Weiske J. (2009). Structure and function of desmosomes during apoptosis: Is there an active contribution? In: Cirillo N, Lanza A, Gombos F, (eds.). Pathophysiology of the Desmosme. Research Signpost, Kerala, India. pp. 63–86.
  • Ihrie RA, Attardi LD (2004). Perp-etrating p53-dependent apoptosis. Cell Cycle. 3: 267–269.
  • Ihrie RA, Attardi LD (2005). A new Perp in the lineup: linking p63 and desmosomal adhesion. Cell Cycle. 4: 873–876.
  • Ihrie RA, Marques MR, Nguyen BT, Horner JS, Papazoglu C, Bronson RT, Mills AA, Attardi LD (2005). Perp is a p63-regulated gene essential for epithelial integrity. Cell. 120: 843–856.
  • Ishii K, Norvell SM, Bannon LJ, Amargo EV, Pascoe LT, Green KJ (2001). Assembly of desmosomal cadherins into desmosomes is isoform dependent. J Invest Dermatol. 117: 26–35.
  • Jennings JM, Tucker DK, Kottke MD, Saito M, Delva E, Hanakawa Y, Amagai M, Kowalczyk AP (2011). Desmosome disassembly in response to pemphigus vulgaris IgG occurs in distinct phases and can be reversed by expression of exogenous Dsg3. J Invest Dermatol. 131: 706–718.
  • Jiang K, Rankin CR, Nava P, Sumagin R, Kamekura R, Stowell SR, Feng M, Parkos CA, Nusrat A (2014). Galectin-3 regulates desmoglein-2 and intestinal epithelial intercellular adhesion. J Biol Chem. 289: 10510–10517.
  • Jiang R, Shi Z, Johnson JJ, Liu Y, Stack MS (2011). Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma. J Biol Chem. 286: 9127–9135.
  • Johns SA, Soullier S, Rashbass P, Cunliffe VT (2005). Foxn1 is required for tissue assembly and desmosomal cadherin expression in the hair shaft. Dev Dyn. 232: 1062–1068.
  • Johnson JL, Koetsier JL, Sirico A, Agidi AT, Antonini D, Missero C, Green KJ (2014). The desmosomal protein desmoglein 1 aids recovery of epidermal differentiation after acute UV light exposure. J Invest Dermatol. 134: 2154–2162.
  • Kalinin AE, Kalinin AE, Aho M, Uitto J, Aho S (2005). Breaking the connection: caspase 6 disconnects intermediate filament-binding domain of periplakin from its actin-binding N-terminal region. J Invest Dermatol. 124: 46–55.
  • Kamekura R, Kolegraff KN, Nava P, Hilgarth RS, Feng M, Parkos CA, Nusrat A (2013). Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signaling. Oncogene. 33: 4531–4536.
  • Kampf C, Relova AJ, Sandler S, Roomans GM (1999). Effects of TNF-α, IFN-γ and IL-β on normal human bronchial epithelial cells. Eur Respir J. 14: 84–91.
  • Kanai Y, Ochiai A, Shibata T, Oyama T, Ushijima S, Akimoto S, Hirohashi S (1995). c-ErbB-2 gene product directly associates with β-catenin and plakoglobin. Biochem Biophys Res Commun. 208: 1067–1072.
  • Ke XS, Qu Y, Rostad K, Li WC, Lin B, Halvorsen OJ, Haukaas SA, Jonassen I, Petersen K, Goldfinger N, Rotter V, Akslen LA, Oyan AM, Kalland KH (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. PLoS One. 4: e4687.
  • Kenchegowda D, Harvey SA, Swamynathan S, Lathrop KL, Swamynathan SK (2012). Critical role of Klf5 in regulating gene expression during post-eyelid opening maturation of mouse corneas. PLoS One. 7: e44771.
  • Khan K, Hardy R, Haq A, Ogunbiyi O, Morton D, Chidgey M (2006). Desmocollin switching in colorectal cancer. Br J Cancer. 95: 1367–1370.
  • Kim C, Wong J, Wen J, Wang S, Wang C, Spiering S, Kan NG, Forcales S, Puri PL, Leone TC, Marine JE, Calkins H, Kelly DP, Judge DP, Chen HS (2013). Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature. 494: 105–110.
  • Klessner JL, Desai BV, Amargo EV, Getsios S, Green KJ (2009). EGFR and ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2. Mol Biol Cell. 20: 328–337.
  • Kljuic A, Bazzi H, Sundberg JP, Martinez-Mir A, O'Shaugnessy R, Mahoney MG, Levy M, Montagutelli X, Ahmad W, Aita VM, Gordon D, Uitto J, Whiting D, Ott J, Fischer S, Gilliam TC, Jahoda CAB, Morris RJ, Panteleyev AA, Nguyen VT, Christiano AM (2003). Desmoglein 4 in hair follicle differentiation and epidermal adhesion: evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell. 113: 249–260.
  • Klus GT, Rokaeus N, Bittner ML, Chen Y, Korz DM, Sukumar S, Schick A, Szallasi Z (2001). Down-regulation of the desmosomal cadherin desmocollin 3 in human breast cancer. Int J Oncol. 19: 169–174.
  • Knösel T, Chen Y, Hotovy S, Settmacher U, Altendorf-Hofmann A, Petersen I (2012). Loss of desmocollin 1–3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma. Int J Colorectal Dis. 27: 1391–1399.
  • Koch PJ, Mahoney MG, Ishikawa H, Pulkkinen L, Uitto J, Shultz L, Murphy GF, Whitaker-Menezes D, Stanley J (1997). Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol. 137: 1091–1102.
  • Kolegraff K, Nava P, Helms MN, Parkos CA, Nusrat A (2011). Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signaling. Mol Biol Cell. 22: 1121–1134.
  • Kume K, Haraguchi M, Hijioka H, Ishida T, Miyawaki A, Nakamura N, Ozawa M (2013). The transcription factor Snail enhanced the degradation of E-cadherin and desmoglein 2 in oral squamous cell carcinoma cells. Biochem Biophys Res Commun. 430: 889–894.
  • Kurzen H, Munzing I, Hartschuh W (2003). Expression of desmosomal proteins in squamous cell carcinomas of the skin. J Cutan Pathol. 30: 621–630.
  • Lanza A, Cirillo N (2007). Caspase-dependent cleavage of desmoglein 1 depends on the apoptotic stimulus. Br J Dermatol. 299: 400–402.
  • Li D, Zhang W, Liu Y, Haneline LS, Shou W (2012). Lack of plakoglobin in epidermis leads to keratoderma. J Biol Chem. 287: 10435–10443.
  • Li G, Schaider H, Satyamoorthy K, Hanakawa Y, Hashimoto K, Herlyn M (2001). Downregulation of E-cadherin and desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Oncogene. 20: 8125–8135.
  • Li L, Chapman K, Hu X, Wong A, Pasdar M (2007a). Modulation of the oncogenic potential of β-catenin by the subcellular distribution of plakoglobin. Mol Carinog. 46: 824–838.
  • Li Q, Dashwood WM, Zhong X, Nakagama H, Dashwood RH (2007b). Bcl-2 overexpression in PhIP-induced colon tumors: cloning of the rat Bcl-2 promoter and characterization of a pathway involving β-catenin, c-myc and E2F1. Oncogene. 26: 6194–6202.
  • Lorch JH, Klessner J, Park JK, Getsios S, Wu YL, Stack MS, Green KJ (2004). Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. J Biol Chem. 279: 37191–37200.
  • Lowndes M, Rakshit S, Shafraz O, Borghi N, Harmon RM, Green KJ, Sivasankar S, Nelson WJ (2014). Different roles of cadherins in the assembly and structural integrity of the desmosome complex. J Cell Sci. 127: 2339–2350.
  • Mahoney MG, Hu Y, Brennan D, Brazzi H, Christiano AM, Wahl JKI (2006). Delineation of diversified desmoglein distribution in stratified squamous epithelia: implications in disease. Exp Dermatol. 15: 101–109.
  • Marcozzi C, Burdett IDJ, Buxton RS, Magee AI (1998). Coexpression of both types of demosomal cadherin and plakoglobin confers strong intercellular adhesion. J Cell Sci. 111: 495–509.
  • Marsden MD, Collins JE, Greenwood MD, Adams MJ, Fleming TP, Magee AI, Buxton RS (1997). Cloning and transcriptional analysis of the promoter of the human type 2 desmocollin gene (DSC2). Gene. 186: 237–247.
  • Merritt AJ, Berika MY, Zhai W, Kirk SE, Ji B, Hardman MJ, Garrod DR (2002). Suprabasal desmoglein 3 expression in the epidermis of transgenic mice results in hyperproliferation and abnormal differentiation. Mol Cell Biol. 22: 5846–5858.
  • Miravet S, Piedra J, Castano J, Raurell I, Franci C, Dunach M, Garcia de Herreros A (2003). Tyrosine phosphorylation of plakoglobin causes contrary effects on its association with desmosomes and adherens junction components and modulates β-catenin-mediated transcription. Mol Cell Biol. 23: 7391–7402.
  • Mlacki M, Darido C, Jane SM, Wilanowski T (2014). Loss of Grainy head-like 1 is associated with disruption of the epidermal barrier and squamous cell carcinoma of the skin. PLoS One. 9: e89247.
  • Moreno V, Gonzalo P, Gomez-Escudero J, Pollan A, Acin-Perez R, Breckenridge M, Yanez-Mo M, Barreiro O, Orsenigo F, Kadomatsu K, Chen CS, Enriquez JA, Dejana E, Sanchez-Madrid F, Arroyo AG (2014). An EMMPRIN/γ-catenin/Nm23 complex drives ATP production and actomyosin contractility at endothelial junctions. J Cell Sci. 127: 3768–3781.
  • Mosesson Y, Mills GB, Yarden Y (2008). Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer. 8: 835–850.
  • Müller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, Sargin B, Köhler G, Stelljes M, Puccetti E, Ruthardt M, deVos S, Hiebert SW, Koeffler HP, Berdel WE, Serve H (2004). Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol. 24: 2890–2904.
  • Murray B, Wagle R, Amat-Alarcon N, Wilkens A, Stephens P, Zackai EH, Goldmuntz E, Calkins H, Deardorff MA, Judge DP (2013). A family with a complex clinical presentation characterized by arrhythmogenic right ventricular dysplasia/cardiomyopathy and features of branchio-oculo-facial syndrome. Am J Med Genet A. 161A: 371–376.
  • Nagashima H, Okada M, Hidai C, Hosoda S, Kasanuki H, Kawana M (1997). The role of cadherin-catenin-cytoskeleton complex in angiogenesis: antisense oligonucleotide of plakoglobin promotes angiogenesis in vitro, and protein kinase C (PKC) enhances angiogenesis through the plakoglobin signaling pathway. Heart Vessels. Suppl 12: 110–112.
  • Nava P, Laukoetter MG, Hopkins AM, Laur O, Gerner-Smidt K, Green KJ, Parkos CA, Nusrat A (2007). Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol Biol Cell. 18: 4565–4578.
  • Nei H, Saito T, Tobioka H, Itoh E, Mori M, Kudo R (1996). Expression of component desmosomal proteins in uterine endometrial carcinoma and their relation to cellular differentiation. Cancer. 78: 461–470.
  • Nekrasova O, Green KJ (2013). Desmosome assembly and dynamics. Trends Cell Biol. 23: 537–546.
  • Nekrasova OE, Amargo EV, Smith WO, Chen J, Kreitzer GE, Green KJ (2011). Desmosomal cadherins utilize distinct kinesins for assembly into desmosomes. J Cell Biol. 195: 1185–1203.
  • Nie Z, Merritt A, Rouhi-Parkouhi M, Tabernero L, Garrod D (2011). Membrane-impermeable cross-linking provides evidence for homophilic, isoform-specific binding of desmosomal cadherins in epithelial cells. J Biol Chem. 286: 2143–2154.
  • Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Brunynel E, Matrisian LM, Mareel M (2001). Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci. 114: 111–118.
  • North AJ, Chidgey MAJ, Clarke JP, Bardsley WG, Garrod DR (1996). Distinct desmocollin isoforms occur in the same desmosome and show reciprocally graded distributions in bovine nasal epidermis. Proc Natl Acad Sci USA. 93: 7701–7705.
  • Nottebaum AF, Cagna G, Winderlich M, Gamp AC, Linnepe R, Polaschegg C, Filippova K, Lyck R, Engelhardt B, Kamenyeva O, Bixel MG, Butz S, Vestweber D (2008). VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. J Exp Med. 205: 2929–2945.
  • Nuber UA, Schäfer S, Schmidt A, Koch PJ, Franke WW (1995). The widespread human desmocollin Dsc2 and tissue-specific patterns of synthesis of various desmocollin subtypes. Eur J Cell Biol. 66: 69–74.
  • Nuber UA, Schäfer S, Stehr S, Rackwitz HR, Franke WW (1996). Patterns of desmocollin synthesis in human epithelia: immunolocalization of desmocollins 1 and 3 in special epithelia and in cultured cells. Eur J Cell Biol. 71: 1–13.
  • Oka D, Yamashita S, Tomioka T, Nakanishi Y, Kato H, Kaminishi M, Ushijima T (2009). The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers. Cancer. 115: 3412–3426.
  • Omori-Miyake M, Yamashita M, Tsunemi Y, Kawashima M, Yagi J (2014). In vitro assessment of IL-4- or IL-13-mediated changes in the structural components of keratinocytes in mice and humans. J Invest Dermatol. 134: 1342–1350.
  • Oshiro MM, Kim CJ, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Burr JA, Fitzgerald M, Pawar SC, Cress AE, Domann FE, Futscher BW (2005). Epigenetic silencing of Dsc3 is a common event in human breast cancer. Breast Cancer Res. 7: R669–R680.
  • Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, Futscher BW (2003). Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene. 22: 3624–3634.
  • Owens P, Bazzi H, Engelking E, Han G, Christiano AM, Wang XJ (2008). Smad4-dependent desmoglein-4 expression contributes to hair follicle integrity. Dev Biol. 322: 156–166.
  • Pan H, Gao F, Papageorgis P, Abdolmaleky HM, Faller DV, Thiagalingam S (2007). Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progression. Cancer Biol Ther. 6: 1638–1643.
  • Pan J, Chen Y, Mo C, Wang D, Chen J, Mao X, Guo S, Zhuang J, Qiu S (2014). Association of Dsc3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis. PLoS One. 9: e92815.
  • Patel DM, Green KJ (2014). Desmosomes in the heart: a review of clinical and mechanistic analyses. Cell Commun Adhes. 21: 109–128.
  • Rennel E, Mellberg S, Dimberg A, Petersson L, Botling J, Ameur A, Westholm JO, Komorowski J, Lassalle P, Cross MJ, Gerwins P (2007). Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer. Exp Cell Res. 313: 1285–1294.
  • Roberts BJ, Pashaj A, Johnson KR, Wahl JK III (2011). Desmosome dynamics in migrating epithelial cells requires the actin cytoskeleton. Exp Cell Res. 317: 2814–2822.
  • Rötzer V, Breit A, Waschke J, Spindler V (2014). Adducin is required for desmosomal cohesion in keratinocytes. J Biol Chem. 289: 14925–14940.
  • Runswick SK, O'Hare MJ, Jones JL, Streuli C, Garrod DR (2001). Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nat Cell Biol. 3: 823–830.
  • Ryan KR, Lock FE, Heath JK, Hotchin NA (2012). Plakoglobin-dependent regulation of keratinocyte apoptosis by Rnd3. J Cell Sci. 125: 3202–3209.
  • Santiago-Josefat B, Esselens C, Bech-Serra JJ, Arribas J (2007). Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors. J Biol Chem. 282: 8325–8331.
  • Savagner P, Yamada KM, Thiery JP (1997). The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol. 137: 1403–1419.
  • Savci-Heijink CD, Kosari F, Aubry MC, Caron BL, Sun Z, Yang P, Vasmatzis G (2009). The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung. Am J Pathol. 174: 1629–1637.
  • Schnittler HJ, Puschel B, Drenckhahn D (1997). Role of cadherins and plakoglobin in interendothelial adhesion under resting conditions and shear stress. Am J Physiol. 273: H2396–2405.
  • Schüle S, Neuhauser C, Rauchfuss F, Knosel T, Settmacher U, Altendorf-Hofmann A (2014). The influence of desmocollin 1–3 expression on prognosis after curative resection of colorectal liver metastases. Int J Colorectal Dis. 29: 9–14.
  • Shafiei F, Rahnama F, Pawella L, Mitchell MD, Gluckman PD, Lobie PE (2008). DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells. Oncogene. 27: 2602–2612.
  • Sherr CJ, McCormick F (2002). The Rb and p53 pathways in cancer. Cancer Cell. 2: 103–112.
  • Shi HJ, Stubbs R, Hood K (2009). Characterization of de novo synthesized proteins released from human colorectal tumour explants. Electrophoresis. 30: 2442–2453.
  • Shiina H, Breault JE, Basset WW, Enokida H, Urakami S, Li LC, Okino ST, Deguchi M, Kaneuchi M, Terashima M, Yoneda T, Shigeno K, Carroll PR, Igawa M, Dahiya R (2005). Functional loss of the γ-catenin gene through epigenetic and genetic pathways in human prostate cancer. Cancer Res. 65: 2130–2138.
  • Shinohara M, Hiraki A, Ikebe T, Nakamura S, Kurahara S, Shirasuna K, Garrod DR (1998). Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour. J Pathol. 184: 369–381.
  • Silos SA, Tamai K, Li K, Kivirikko S, Kouba D, Chritiano AM, Uitto J (1996). Cloning of the gene for human pemphigus vulgaris antigen (desmoglein 3), a desmosomal cadherin. Characterization of the promoter region and identification of a keratinocyte-specific cis element. J Biol Chem. 271: 17504–17511.
  • Simpson DL, Patel DM, Green KJ (2011). Deconstructing the skin: cytoarchitectural determinants of epidermal morphogenesis. Nat Rev Mol Cell Biol. 12: 565–580.
  • Spindler V, Waschke J (2014). Desmosomal cadherins and signaling: lessons from autoimmune disease. Cell Commun Adhes. 21: 77–84.
  • Stahley SN, Saito M, Faundez V, Koval M, Mattheyses AL, Kowalczyk AP (2014). Desmosome assembly and disassembly are membrane raft-dependent. PLoS One. 9: e87809.
  • Syed S, Trinnaman B, Martin S, Major S, Hutchinson J, Magee AI (2002). Molecular interactions between desmosomal cadherins. Biochem J. 362: 317–327.
  • Tada H, Hatoko M, Tanaka A, Kuwahara M, Muramatsu T (2000). Expression of desmoglein I and plakoglobin in skin carcinomas. J Cutan Pathol. 27: 24–29.
  • Todorovic V, Desai BV, Patterson MJ, Amargo EV, Dubash AD, Yin T, Jones JC, Green KJ (2010). Plakoglobin regulates cell motility through Rho- and fibronectin-dependent Src signaling. J Cell Sci. 123: 3576–3586.
  • Tokonzaba E, Chen J, Cheng X, Den Z, Ganeshan R, Muller EJ, Koch PJ (2013). Plakoglobin as a regulator of desmocollin gene expression. J Invest Dermatol. 133: 2732–2740.
  • Tsang SM, Brown L, Gadmor H, Gammon L, Fortune F, Wheeler A, Wan H (2012a). Desmoglein 3 acting as an upstream regulator of Rho GTPases, Rac-1/Cdc42 in the regulation of actin organisation and dynamics. Exp Cell Res. 318: 2269–2283.
  • Tsang SM, Brown L, Lin K, Liu L, Piper K, O’Toole EA, Grose R, Hart IR, Garrod DR, Fortune F, Wan H (2012b). Non-junctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris. J Pathol. 227: 81–93.
  • Tsang SM, Liu L, Teh MT, Wheeler A, Grose R, Hart IR, Garrod DR, Fortune F, Wan H (2010). Desmoglein 3, via an interaction with E-cadherin, is associated with activation of Src. PLoS One. 5: e14211.
  • Tselepis C, Chidgey M, North A, Garrod DR (1998). Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci USA. 95: 8064–8069.
  • Valentijn AJ, Zouq N, Gilmore AP (2004). Anoikis. Biochem Soc Trans. 32: 421–425.
  • van Roy F (2014). Beyond E-cadherin: roles of other cadherin superfamily members in cancer. Nat Rev Cancer. 14: 121–134.
  • Vandewalle C, Comijn J, De Craene B, Vermassen P, Bruyneel E, Andersen H, Tulchinsky E, Van Roy F, Berx G (2005). SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 33: 6566–6578.
  • Venkiteswaran K, Xiao K, Summers S, Calkins CC, Vincent PA, Pumiglia K, Kowalczyk AP (2002). Regulation of endothelial barrier function and growth by VE-cadherin, plakoglobin, and β-catenin. Am J Physiol Cell Physiol. 283: C811–821.
  • Wang Q, Peng D, Zhu S, Chen Z, Hu T, Soutto M, Saad R, Zhang S, Ei-Rifai W (2014). Regulation of desmocollin3 expression by promoter hypermethylation is associated with advanced esophageal adenocarcinomas. J Cancer. 5: 457–464.
  • Waschke J, Menendez-Castro C, Bruggman P, Koob R, Amagai M, Gruber HJ, Drenckhahn D, Baumgartner W (2007). Imaging and force spectroscopy on desmoglein 1 using atomic force microscopy reveal multivalent Ca2+-dependent, low-affintiy trans-interactions. J Membr Biol. 216: 83–92.
  • Waschke J, Spindler V, Bruggeman P, Zillikens D, Schmidt G, Drenckhahn D (2006). Inhibition of Rho A activity causes pemphigus skin blistering. J Cell Biol. 175: 721–727.
  • Weiske J, Schöneberg T, Schröder W, Hatzfeld M, Tauber R, Huber O (2001). The fate of desmosomal proteins in apoptotic cells. J Biol Chem. 276: 41175–41181.
  • Wheelock MJ, Buck CA, Bechtol KB, Damsky CH (1987). Soluble 80-kd fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J Cell Biochem. 34: 187–202.
  • Wilanowski T, Caddy J, Ting SB, Hislop NR, Cerruti L, Auden A, Zhao LL, Asquith S, Ellis S, Sinclair R, Cunningham JM, Jane SM (2008). Perturbed desmosomal cadherin expression in grainy head-like 1-null mice. EMBO J. 27: 886–897.
  • Williamson L, Raess NA, Caldelari R, Zakher A, de Bruin A, Posthaus H, Bolli R, Hunziker T, Suter MM, Müller EJ (2006). Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in skin. EMBO J. 25: 3298–3309.
  • Winn RA, Bremnes RM, Bemis L, Franklin WA, Miller YE, Cool C, Heasley LE (2002). γ-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene. 21: 7497–7506.
  • Wolf A, Rietscher K, Glass M, Hüttelmeier S, Schutkowski M, Ihling C, Sinz A, Wingenfeld A, Mun A, Hatzfeld M (2013). Insulin signaling via Akt2 switches plakophilin 1 function from stabilizing cell adhesion to promoting cell proliferation. J Cell Sci. 126: 1832–1844.
  • Wong MP, Cheang M, Yorida E, Coldman A, Gilks CB, Huntsman D, Berean K (2008). Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients. Pathology. 40: 611–616.
  • Wu SK, Yap AS (2013). Patterns in space: Coordinating adhesion and actomyosin contractility at E-cadherin junctions. Cell Commun Adhes. 20: 201–212.
  • Xin Z, Yamaguchi A, Sakamoto K (2014). Aberrant expression and altered cellular localization of desmosomal and hemidesmosomal proteins are associated with aggressive clinicopathological features of oral squamous cell carcinoma. Virchows Arch. 465: 35–47.
  • Yang L, Chen Y, Cui T, Knosel T, Zhang Q, Albring KF, Huber O, Petersen I (2012). Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer. Carcinogenesis. 33: 1863–1870.
  • Yashiro M, Nishioka N, Hirakawa K (2006). Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma. Eur J Cancer. 42: 2397–2403.
  • Yin T, Getsios S, Caldelari R, Godsel LM, Kowalczyk AP, Muller EJ, Green KJ (2005). Mechanisms of plakoglobin-dependent adhesion: desmosome-specific functions in assembly and regulation by epidermal growth factor receptor. J Biol Chem. 280: 40355–40363.
  • Yin T, Getsios S, Caldelari R, Kowalczyk AP, Müller EJ, Jones JCR, Green KJ (2004). Plakoglobin suppresses keratinocyte motility through both cell-cell adhesion-dependent and -independent mechanisms. Proc Natl Acad Sci USA. 102: 5420–5425.
  • Zhang Y, Toh L, Lau P, Wang X (2012). Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer. J Biol Chem. 287: 32494–32511.
  • Zhou X, Stuart A, Dettin LE, Rodriguez G, Hoel B, Gallicano GI (2004). Desmoplakin is required for microvascular tube formation in culture. J Cell Sci. 117: 3129–3140.
  • Zuckerman JD, Lee WY, DelGaudio JM, Moore CE, Nava P, Nusrat A, Parkos CA (2008). Pathophysiology of nasal polyposis: the role of desmosomal junctions. Am J Rhinol. 22: 589–597.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.